Skip to main content
All lobbying filings

ESSILORLUXOTTICA USA INC.

Lobbying for ESSILORLUXOTTICA USA INC. · Vision care and eyewear.

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 13, 2026
Expenses
$300,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem